Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avicanna (AVCNF)
OTHER OTC:AVCNF
Holding AVCNF?
Track your performance easily
AVCNF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.16 - $0.53
Previous Close$0.19
Volume1.20K
Average Volume (3M)15.70K
Market Cap
$20.79M
Enterprise Value$27.24M
Total Cash (Recent Filing)C$488.21K
Total Debt (Recent Filing)C$1.57M
Price to Earnings (P/E)―
Beta0.64
Next Earnings
Mar 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding106,910,000
10 Day Avg. Volume13,710
30 Day Avg. Volume15,701
Standard Deviation0.27
R-Squared0.17
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)1.05
Price to Cash Flow (P/CF)-3.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Avicanna News
PremiumCompany Announcements
Avicanna Shows Strong Revenue Growth and Improved Margins
PremiumCompany Announcements
Avicanna Secures $800K in Private Placement
PremiumCompany Announcements
Avicanna Launches Major Cannabis Effects Study
PremiumCompany Announcements
Avicanna Clears Debt, Advances Cannabinoid Solutions
PremiumCompany Announcements
Avicanna Completes Private Placement FundraisingPremiumCompany Announcements
Avicanna Secures US Patent for Pain-Relief Topical TechnologyOptions Prices
Currently, No data available
---
Ownership Overview
31.25% Insiders
<0.01% Other Institutional Investors
68.74% Public Companies and
Individual Investors
AVCNF FAQ
What was Avicanna’s price range in the past 12 months?
Avicanna lowest stock price was $0.15 and its highest was $0.53 in the past 12 months.
What is Avicanna’s market cap?
Currently, no data Available
When is Avicanna’s upcoming earnings report date?
Avicanna’s upcoming earnings report date is Mar 28, 2025 which is in 126 days.
How were Avicanna’s earnings last quarter?
Avicanna released its earnings results on Nov 14, 2024. The company reported -$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.006.
Is Avicanna overvalued?
According to Wall Street analysts Avicanna’s price is currently Overvalued.
Does Avicanna pay dividends?
Avicanna does not currently pay dividends.
What is Avicanna’s EPS estimate?
Avicanna’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Avicanna have?
Avicanna has 109,572,395 shares outstanding.
What happened to Avicanna’s price movement after its last earnings report?
Avicanna reported an EPS of -$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.526%.
Which hedge fund is a major shareholder of Avicanna?
Currently, no hedge funds are holding shares in AVCNF
---
Avicanna Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $1.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.11%
12-Months-Change
Fundamentals
Return on Equity
-434.30%
Trailing 12-Months
Asset Growth
-17.07%
Trailing 12-Months
Company Description
Avicanna
Avicanna is an Ontario corporation focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products via its two main business segments, cultivation and R&D With two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for Avicanna's cultivation activities. These companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including CBD and THC. Avicanna's research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto. Avicanna has engaged the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto.
---
AVCNF Earnings Call
Q4 2024
0:00 / 0:00
---
Technical Analysis
---